Literature DB >> 30614226

A systematic review of herbal medicines for the treatment of cancer cachexia in animal models.

Bongki Park1, Sooseong You2, William C S Cho3, Jun-Yong Choi4, Myeong Soo Lee2.   

Abstract

OBJECTIVE: The aim of this study is to summarize preclinical studies on herbal medicines used to treat cancer cachexia and its underlying mechanisms.
METHODS: We searched four representing databases, including PubMed, EMBASE, the Allied and Complementary Medicine Database, and the Web of Science up to December 2016. Randomized animal studies were included if the effects of any herbal medicine were tested on cancer cachexia. The methodological quality was evaluated by the Collaborative Approach to Meta-Analysis and Review of Animal Data from Experimental Studies (CAMARADE) checklist.
RESULTS: A total of fourteen herbal medicines and their compounds were identified, including Coptidis Rhizoma, berberine, Bing De Ling, curcumin, Qing-Shu-Yi-Qi-Tang, Scutellaria baicalensis, Hochuekkito, Rikkunshito, hesperidin, atractylodin, Sipjeondaebo-tang, Sosiho-tang, Anemarrhena Rhizoma, and Phellodendri Cortex. All the herbal medicines, except curcumin, have been shown to ameliorate the symptoms of cancer cachexia through anti-inflammation, regulation of the neuroendocrine pathway, and modulation of the ubiquitin proteasome system or protein synthesis.
CONCLUSIONS: This study showed that herbal medicines might be a useful approach for treating cancer cachexia. However, more detailed experimental studies on the molecular mechanisms and active compounds are needed.

Entities:  

Keywords:  Cancer; Cachexia; Herbal medicine; Traditional East Asian medicine systematic review

Mesh:

Year:  2019        PMID: 30614226      PMCID: PMC6331334          DOI: 10.1631/jzus.B1800171

Source DB:  PubMed          Journal:  J Zhejiang Univ Sci B        ISSN: 1673-1581            Impact factor:   3.066


  9 in total

Review 1.  Sarcopenia versus cancer cachexia: the muscle wasting continuum in healthy and diseased aging.

Authors:  Alexandra Moreira-Pais; Rita Ferreira; Paula A Oliveira; José A Duarte
Journal:  Biogerontology       Date:  2021-07-29       Impact factor: 4.277

2.  Myricanol 5-fluorobenzyloxy ether regulation of survivin pathway inhibits human lung adenocarcinoma A549 cells growth in vitro.

Authors:  Guan-Hai Dai; Xuan Chen; Ze-Ming Ren; Chen-Jie Dai; Ye-Ling Tong; Ke-Qun Chai
Journal:  BMC Complement Med Ther       Date:  2020-09-03

3.  Effects of Cortex Phellodendri extract on post-weaning piglets diarrhoea.

Authors:  Xiaofan Xu; Yunxin Pan; Baoyang Xu; Yiqin Yan; Boqi Yin; Yanqing Wang; Shuxin Hu; Libao Ma
Journal:  Vet Med Sci       Date:  2020-06-25

4.  Curcumin alleviates LPS-induced inflammation and oxidative stress in mouse microglial BV2 cells by targeting miR-137-3p/NeuroD1.

Authors:  Feng Gao; Jing Lei; Zhaowei Zhang; Yanling Yang; Haojun You
Journal:  RSC Adv       Date:  2019-11-25       Impact factor: 4.036

Review 5.  Shared and Divergent Epigenetic Mechanisms in Cachexia and Sarcopenia.

Authors:  Laura Yedigaryan; Martina Gatti; Vittoria Marini; Tullia Maraldi; Maurilio Sampaolesi
Journal:  Cells       Date:  2022-07-25       Impact factor: 7.666

6.  Extracts of Knoxia roxburghii (Spreng.) M. A. Rau Induce Apoptosis in Human MCF-7 Breast Cancer Cells via Mitochondrial Pathways.

Authors:  Xiao-Jiao Chen; Xin-Ying Pu; Xue-Mei Pu; Xue Li; Zhi-Bo Liu; Mi-Jia Mei; Xin-Ge Wang; Fan Zhang; Bin Qiu; Jie Yu
Journal:  Molecules       Date:  2022-09-29       Impact factor: 4.927

7.  Preclinical Investigation of Alpinetin in the Treatment of Cancer-Induced Cachexia via Activating PPARγ.

Authors:  Yujie Zhang; Yuxin Zhang; Yichen Li; Li Zhang; Shiying Yu
Journal:  Front Pharmacol       Date:  2021-05-21       Impact factor: 5.810

Review 8.  Recent Advances in Anti-Metastatic Approaches of Herbal Medicines in 5 Major Cancers: From Traditional Medicine to Modern Drug Discovery.

Authors:  Jinkyung Park; Dahee Jeong; Meeryoung Song; Bonglee Kim
Journal:  Antioxidants (Basel)       Date:  2021-03-27

Review 9.  Current Advances in Coptidis Rhizoma for Gastrointestinal and Other Cancers.

Authors:  Luying He; Zhangfeng Zhong; Man Chen; Qilian Liang; Yitao Wang; Wen Tan
Journal:  Front Pharmacol       Date:  2022-01-03       Impact factor: 5.988

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.